SeniorJournal.com |
FDA approves Striverdi Respimat for COPD, includes asthma warning
Healio “The safety and effectiveness of Striverdi Respimat in people with asthma has not been established, and it is not approved to treat asthma,” the release said. “Striverdi Respimat should not be used as a rescue therapy to treat sudden breathing problems … FDA Clears Olodaterol (Striverdi Respimat) for COPD Once-Daily Inhaler Approved for COPD FDA approves Boehringer's once-a-day inhaler drug |
View full post on asthma – Google News